Drug Shortage Report for APO-TADALAFIL

Last updated on 2021-09-14 History
Report ID 144669
Drug Identification Number 02422107
Brand name APO-TADALAFIL
Common or Proper name TADALAFIL
Company Name APOTEX INC
Market Status MARKETED
Active Ingredient(s) TADALAFIL
Strength(s) 10MG
Dosage form(s) TABLET
Route of administration ORAL ORAL
Packaging size 4 BLS
ATC code G04BE
ATC description OTHER UROLOGICALS, INCL ANTISPASMODICS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2021-08-24
Estimated end date 2021-09-10
Actual end date 2021-09-10
Shortage status Resolved
Updated date 2021-09-14
Company comments
Health Canada comments
Contact Address 150 SIGNET DRIVE
TORONTO, ONTARIO
CANADA M9L 1T9
Company contact information Apotex Customer Service - 1-877-427-6839

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v4 2021-09-14 French Compare
v3 2021-09-14 English Compare
v2 2021-08-27 French Compare
v1 2021-08-27 English Compare